Drug Type Small molecule drug |
Synonyms SNX-001 |
Target |
Action inhibitors |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaCH3FO2S |
InChIKeyKNWQLFOXPQZGPX-UHFFFAOYSA-N |
CAS Registry558-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | Mexico | - | - |
Cognition Disorders | Preclinical | United States | - |
Not Applicable | - | - | Methanesulfonyl fluoride [MSF] | psrkzyyrer(mcuvbdkytj) = Male cortex showed decreases in width while female cortex showed increases; all significant changes were limited to anterior cortical areas krzbvcdhwc (pxtpydjxsc ) View more | - | 11 Nov 2003 | |
Vehicle (VEH) |